Emerging Viral Infections
暂无分享,去创建一个
[1] M. Fernández-Guarino,et al. Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital , 2020, Clinical and experimental dermatology.
[2] J. Lipoff,et al. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries , 2020, Journal of the American Academy of Dermatology.
[3] I. Betlloch-Más,et al. Are chilblain‐like acral skin lesions really indicative of COVID‐19? A prospective study and literature review , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] J. Fraga,et al. Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID‐19 , 2020, The British journal of dermatology.
[5] P. Anfinrud,et al. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission , 2020, Proceedings of the National Academy of Sciences.
[6] Parantu K. Shah,et al. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial , 2020, Journal for immunotherapy of cancer.
[7] A. Torrelo,et al. Chilblains in children in the setting of COVID‐19 pandemic , 2020, Pediatric dermatology.
[8] M. Ziv,et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature , 2020, Journal of Dermatological Science.
[9] D. Najarian. Morbilliform exanthem associated with COVID-19 , 2020, JAAD Case Reports.
[10] G. Fabbrocini,et al. Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients , 2020, Journal of the American Academy of Dermatology.
[11] A. Chughtai,et al. Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019? , 2020, The Journal of infectious diseases.
[12] David Berlin,et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.
[13] Xiaoping Zhou,et al. 合并肢端缺血表现的危重型新型冠状病毒肺炎七例临床分析 , 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[14] Dengju Li,et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.
[15] S. Recalcati. Cutaneous manifestations in COVID‐19: a first perspective , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[16] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[17] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[18] M. Ciccozzi,et al. The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.
[19] J. Singleton,et al. Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 — National Immunization Survey-Child, United States, 2016–2018 , 2019, MMWR. Morbidity and mortality weekly report.
[20] L. Abu-Raddad,et al. Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics , 2019, PloS one.
[21] T. Mrkvan,et al. The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis. , 2019, Vaccine.
[22] Penghua Wang,et al. Genetic Determinants of the Re-Emergence of Arboviral Diseases , 2019, Viruses.
[23] K. Ruxrungtham,et al. Dengue vaccine: Global development update. , 2019, Asian Pacific journal of allergy and immunology.
[24] Jose Dario Martinez,et al. Going Viral 2019: Zika, Chikungunya, and Dengue. , 2019, Dermatologic clinics.
[25] G. Ebel,et al. Arbovirus coinfection and co-transmission: A neglected public health concern? , 2019, PLoS biology.
[26] S. Tyring,et al. Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise. , 2018, Cutis.
[27] A. Tricco,et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis , 2018, British Medical Journal.
[28] J. Grob,et al. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial , 2018, JAMA oncology.
[29] Hoang Minh Tu Van,et al. Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam , 2018, Emerging infectious diseases.
[30] K. Lewis,et al. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial , 2018, Journal of Immunotherapy for Cancer.
[31] P. Shi,et al. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly , 2017, Science.
[32] S. Dutta,et al. Association of toll-like receptor polymorphisms with susceptibility to chikungunya virus infection. , 2017, Virology.
[33] A. M. Bispo de Filippis,et al. Neurologic Complications Associated With the Zika Virus in Brazilian Adults , 2017, JAMA neurology.
[34] S. Tyring,et al. Dysregulation of the MEK/ERK/MNK1 signalling cascade by middle T antigen of the trichoydsplasia spinulosa polyomavirus , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[35] C. Cockerell,et al. Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses , 2017, Journal of the American Academy of Dermatology.
[36] D. Galloway,et al. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study , 2017, Cancer.
[37] Penny A. Rudd,et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. , 2017, The Lancet. Infectious diseases.
[38] Oliver H. Chang,et al. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. , 2017, The Journal of investigative dermatology.
[39] S. Tyring,et al. Molecular mechanisms supporting a pathogenic role for human polyomavirus 6 small T antigen: Protein phosphatase 2A targeting and MAPK cascade activation , 2017, Journal of medical virology.
[40] D. Jungkind,et al. Chikungunya Virus , 2017, Clinics in Laboratory Medicine.
[41] G. Boivin,et al. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management , 2016, Current opinion in infectious diseases.
[42] A. Sauerbrei. Herpes Genitalis: Diagnosis, Treatment and Prevention , 2016, Geburtshilfe und Frauenheilkunde.
[43] Jairo Lizarazo,et al. Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia. , 2016, The New England journal of medicine.
[44] G. Linette,et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. , 2016, The Lancet. Oncology.
[45] S. Tyring,et al. Small T‐antigen of the TS‐associated polyomavirus activates factors implicated in the MAPK pathway , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[46] V. Sondak,et al. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma , 2016, Annals of Surgical Oncology.
[47] A. Sober,et al. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System , 2016, Annals of Surgical Oncology.
[48] Drew M. Pardoll,et al. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. , 2016, The New England journal of medicine.
[49] Jianguo Li,et al. Genomic features of coxsackievirus A6 correlate with herpangina and hand, foot and mouth disease , 2016 .
[50] Yu Lin,et al. New strategies against drug resistance to herpes simplex virus , 2016, International Journal of Oral Science.
[51] L. Schuler‐Faccini,et al. Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. , 2016, MMWR. Morbidity and mortality weekly report.
[52] K. Looker,et al. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012 , 2015, PloS one.
[53] N. Safdar,et al. The Reemergence of Measles , 2015, Current Infectious Disease Reports.
[54] T. Fitzgerald,et al. Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States , 2015, The American surgeon.
[55] Shinn-Jang Hwang,et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. , 2015, The New England journal of medicine.
[56] J. Ho,et al. Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. , 2015, The Journal of infectious diseases.
[57] A. Giuliano,et al. Natural history of polyomaviruses in men: the HPV infection in men (HIM) study. , 2015, The Journal of infectious diseases.
[58] M. Diebold,et al. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. , 2015, Human pathology.
[59] P. Coursaget,et al. Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity , 2015, Neuroendocrinology.
[60] S. Roman,et al. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients. , 2015, JAMA otolaryngology-- head & neck surgery.
[61] M. Chababi-Atallah,et al. Trichodysplasia Spinulosa in a Renal Transplant Patient , 2015, Journal of cutaneous medicine and surgery.
[62] G. Gabutti,et al. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine , 2014, Journal of preventive medicine and hygiene.
[63] M. Levin. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[64] J. Becker,et al. Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations. , 2014, JAMA dermatology.
[65] S. Tyring,et al. Binding of the trichodysplasia spinulosa-associated polyomavirus small T antigen to protein phosphatase 2A: elucidation of a potential pathogenic mechanism in a rare skin disease. , 2014, JAMA dermatology.
[66] Taro Yamamoto,et al. On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling. , 2014, Journal of vector borne diseases.
[67] W. Kwan,et al. Outcomes of Merkel Cell Carcinoma Treated with Radiotherapy without Radical Surgical Excision , 2014, Annals of Surgical Oncology.
[68] M. Hellmich,et al. Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. , 2014, The Journal of general virology.
[69] G. Mcquillan,et al. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. , 2014, The Journal of infectious diseases.
[70] S. Tyring,et al. Varicella zoster: an update on current treatment options and future perspectives , 2014, Expert opinion on pharmacotherapy.
[71] O. Faye,et al. Molecular Evolution of Zika Virus during Its Emergence in the 20th Century , 2014, PLoS neglected tropical diseases.
[72] M. Feltkamp,et al. Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin , 2013, PloS one.
[73] B. King,et al. Atypical Hand-Foot-Mouth Disease Associated with Coxsackievirus A6 Infection , 2018 .
[74] A. Sette,et al. Local CD4 and CD8 T-Cell Reactivity to HSV-1 Antigens Documents Broad Viral Protein Expression and Immune Competence in Latently Infected Human Trigeminal Ganglia , 2013, PLoS pathogens.
[75] M. Feltkamp,et al. The trichodysplasia spinulosa‐associated polyomavirus: virological background and clinical implications , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[76] J. Temte,et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[77] S. Tyring. Vaccination of older adults against herpes zoster is safe and effective , 2013, Evidence-Based Medicine.
[78] Gary Dubin,et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[79] M. Pawlita,et al. C‐terminal deletions of Merkel cell polyomavirus large T‐antigen, a highly specific surrogate marker for virally induced malignancy , 2012, International journal of cancer.
[80] C. Drachenberg,et al. Specific detection of trichodysplasia spinulosa–associated polyomavirus DNA in skin and renal allograft tissues in a patient with trichodysplasia spinulosa. , 2012, Archives of dermatology.
[81] J. Ring,et al. Histological, Immunohistological, and Clinical Features of Merkel Cell Carcinoma in Correlation to Merkel Cell Polyomavirus Status , 2012, Journal of skin cancer.
[82] E. Robertson,et al. Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights. , 2012, Archives of dermatology.
[83] O. Ruuskanen,et al. Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. , 2011, The Journal of infectious diseases.
[84] Yuan Chang,et al. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. , 2011, The Journal of clinical investigation.
[85] Robert L. Garcea,et al. Taxonomical developments in the family Polyomaviridae , 2011, Archives of Virology.
[86] O. Ruuskanen,et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[87] A. Shafritz,et al. The herpetic whitlow. , 2011, The Journal of hand surgery.
[88] Kuender D Yang,et al. DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation , 2011, PLoS neglected tropical diseases.
[89] V. Sondak,et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. , 2010, Journal of the American Academy of Dermatology.
[90] Jun Wang,et al. Merkel cell carcinoma. , 2010, Archives of pathology & laboratory medicine.
[91] M. Omeñaca,et al. Onychomadesis outbreak linked to hand, foot, and mouth disease, Spain, July 2008. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[92] A. Dipchand,et al. Trichodysplasia Spinulosa—A Rare Complication in Immunosuppressed Patients , 2010, Pediatric dermatology.
[93] D. Morrell,et al. Viral-associated trichodysplasia of immunosuppression: report of a pediatric patient with response to oral valganciclovir. , 2010, Archives of dermatology.
[94] R. Sanjuán,et al. Viral Mutation Rates , 2010, Journal of Virology.
[95] M. Feltkamp,et al. Discovery of a New Human Polyomavirus Associated with Trichodysplasia Spinulosa in an Immunocompromized Patient , 2010, PLoS pathogens.
[96] C. Buck,et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. , 2010, Cell host & microbe.
[97] L. Eggertson. Lancet retracts 12-year-old article linking autism to MMR vaccines , 2010, Canadian Medical Association Journal.
[98] T. Hyypiä,et al. Coxsackievirus A6 and Hand, Foot, and Mouth Disease, Finland , 2009, Emerging infectious diseases.
[99] J. Becker,et al. Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus , 2009, PLoS pathogens.
[100] Yuan Chang,et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.
[101] K. Morita,et al. Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome , 2008, PLoS neglected tropical diseases.
[102] R. Brodell,et al. The treatment of herpes simplex infections: an evidence-based review. , 2008, Archives of internal medicine.
[103] Arash Mostaghimi,et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.
[104] J. Seward,et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. , 2008, The Journal of infectious diseases.
[105] P. Moore,et al. Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.
[106] T. Liesegang. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. , 2008, Ophthalmology.
[107] L. Salleras. Mass vaccination: global aspects – Progress and obstacles. Plotkin SA, editor. Current Topics in Microbiology and Immunology (CTMI) 2006;304:1-271. Heidelberg: Springer-Verlag. 271 páginas. , 2007 .
[108] R. Muirhead,et al. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[109] D. Kimberlin. Herpes simplex virus infections of the newborn. , 2007, Seminars in perinatology.
[110] A. Geretti,et al. Herpes simplex virus type 2: epidemiology and management options in developing countries , 2006, Postgraduate Medical Journal.
[111] U. Heininger,et al. Varicella , 2006, The Lancet.
[112] J. Kaldor,et al. Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study. , 2006, The Journal of infectious diseases.
[113] S. Manrubia,et al. Viral evolution , 2006, Physics of Life Reviews.
[114] John G Beauman. Genital herpes: a review. , 2005, American family physician.
[115] Anavaj Sakuntabhai,et al. A variant in the CD209 promoter is associated with severity of dengue disease , 2005, Nature Genetics.
[116] M. Wallace,et al. Varicella-Zoster Virus Transfer to Skin by T Cells and Modulation of Viral Replication by Epidermal Cell Interferon-α , 2004, The Journal of experimental medicine.
[117] D. Rouse,et al. Clinical practice. Genital herpes. , 2004, The New England journal of medicine.
[118] B. Anderson. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. , 2003, Medicine and science in sports and exercise.
[119] A. Wollenberg,et al. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. , 2003, The Journal of allergy and clinical immunology.
[120] David Sutton,et al. Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy , 2003, Clinical Microbiology Reviews.
[121] G. Hoekzema,et al. Neonatal herpes simplex virus infections. , 2002, American family physician.
[122] J. Goedert,et al. Merkel cell carcinoma and HIV infection , 2002, The Lancet.
[123] H. Agut,et al. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[124] N. White,et al. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.
[125] G. Campadelli-Fiume,et al. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells , 2000, Reviews in medical virology.
[126] J. Sundberg,et al. Trichodysplasia spinulosa--a newly described folliculocentric viral infection in an immunocompromised host. , 1999, The journal of investigative dermatology. Symposium proceedings.
[127] Z. Smetana,et al. The Natural History of Primary Herpes Simplex Type 1 Gingivostomatitis in Children , 1999, Pediatric dermatology.
[128] Lim Vk. Emerging and re-emerging infections. , 1999, The Medical journal of Malaysia.
[129] C. Bunker,et al. Merkel cell carcinoma arising after therapeutic immunosuppression , 1997, The British journal of dermatology.
[130] J. Zeh,et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. , 1995, The New England journal of medicine.
[131] J. Zeh,et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. , 1995, Archives of family medicine.
[132] H. Balfour,et al. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. , 1994, Journal of acquired immune deficiency syndromes.
[133] J. Modlin,et al. Aseptic meningitis in infants < 2 years of age: diagnosis and etiology. , 1993, The Journal of infectious diseases.
[134] D. Campoli-Richards,et al. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. , 1989, Drugs.
[135] M. Sawyer,et al. Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention , 1988 .
[136] L. Corey,et al. Laboratory diagnosis of herpes simplex virus infections. Principles guiding the development of rapid diagnostic tests. , 1986, Diagnostic microbiology and infectious disease.
[137] K. Holmes,et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.
[138] R. P. Mehta,et al. Ramsay - Hunt Syndrome. , 1980, Indian journal of dermatology, venereology and leprology.
[139] R. Douglas,et al. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. , 1970, Journal of immunology.
[140] J. P. Tindall,et al. Hand-foot-and-mouth disease. , 1968, JAMA.
[141] T. H. Weller,et al. The etiology of epidemic pleurodynia: a study of two viruses isolated from a typical outbreak. , 1950, Journal of immunology.
[142] A. Ross. Possible association between Zika virus infection and microcephaly , 2016 .
[143] L. Hughey,et al. Trichodysplasia of immunosuppression treated with oral valganciclovir. , 2009, Journal of the American Academy of Dermatology.
[144] M. Rowbotham,et al. Recommendations for the management of herpes zoster. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[145] C. Prober,et al. Pathogenesis and disease , 2007 .
[146] J. Amir. Clinical Aspects and Antiviral Therapy in Primary Herpetic Gingivostomatitis , 2001, Paediatric drugs.
[147] A. Arvin,et al. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. , 1996, Advances in virus research.
[148] K. Edwards,et al. Predictors of Morbidity and Mortality in Neonates with Herpes Simplex Virus Infections , 1992 .
[149] B. Simmons,et al. Pediatric herpetic hand infections. , 1990, The Journal of hand surgery.